Sponsor Dossier
Mundipharma
Sponsor Dossier for Mundipharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ARX-Oxycodone/Naloxone
- Brand: BI ELIGARD CP
- Brand: BUPREDERMAL
- Brand: COSOPT
- Brand: DILAUDID
- Brand: DILAUDID-HP
- Brand: ELIGARD
- Brand: FLUTIFORM
- Device (sponsor): First aid kit, non-medicated, single-use
- Device (sponsor): Dressing, hydrogel
About
Mundipharma is an Australian Private Company with ABN 87081322509, registered in NSW and currently active.
Portfolio
Mundipharma has 22 brands on the ARTG, of which 20 are indexable and 20 carry a Product Information document. 17 brands are PBS-listed, 10 have a PBAC outcome on record, and 5 have an AusPAR on record. Notable brands include ARX-Oxycodone/Naloxone, BI ELIGARD CP, BUPREDERMAL, COSOPT, DILAUDID, DILAUDID-HP, ELIGARD, FLUTIFORM, FOLOTYN, MPL- OXYCODONE/NALOXONE, MPL-BICALUTAMIDE, MS.
Therapeutic focus
— Pain Management: 12 brands — Ophthalmology: 5 brands — Oncology: 4 brands — Respiratory: 1 brand
PBS footprint
17 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2024-11-01, across 10 brands with a PBAC outcome on record. The latest AusPAR is 2023-03-14, across 5 brands with an AusPAR on record.